Dr. Antony Kam joined the Department of Biological Sciences, School of Science at Xi’an Jiaotong-Liverpool University as an Assistant Professor in 2023. He graduated with a Bachelor of Pharmacy (Honours) degree (2010) and a Ph.D. in Pharmacy (2015) from the Faculty of Pharmacy, University of Sydney, Australia, focusing on natural product pharmacology. After graduation, he was appointed first as a Research Fellow, and later, promoted to Senior Research Fellow, at the School of Biological Sciences, Nanyang Technological University, Singapore, under the supervision of a world-renowned peptide chemist, Professor James P. Tam (2014-2023).

Dr. Kam's research interests center around peptide/protein drug discovery and translational research for applications in precision medicine, cosmeceuticals, theranostic, and food science. Since 2010, Dr. Kam has published over 40 peer-reviewed articles in well-recognized journals such as Journal of the American Chemical Society, Angewandte Chemie, Journal of Medicinal Chemistry, Journal of Biological Chemistry, Acta Pharmaceutica Sinica B, Frontiers in Pharmacology, and Frontiers in Plant Sciences. He also holds two US and China national phase patent applications related to the discovery of hyperstable epidermal growth factor receptor agonists for wound healing, cosmetics, and cellular agriculture applications.  

Led by Dr. Antony Kam (Department of Biological Sciences) and Dr. Shining Loo (Wisdom Lake Academy of Pharmacy) at Xi'an JiaoTong Liverpool University, XPad (XJTLU Peptide and Drug) is a collaborative research group at the forefront of peptide-based technologies. We leverage our expertise in molecular pharmacology, synthetic biology, and chemical biology to develop innovative solutions for:

• Therapeutics: Designing next-generation drugs with targeted precision to combat various diseases.

• Diagnostics: Creating highly accurate and personalized medical tests for early disease detection and personalized treatment.

• Biomaterials: Engineering advanced materials for tissue regeneration and repair, promoting healing and improving lives.

• Drug Delivery Systems: Revolutionizing how therapeutics are delivered safely and effectively, maximizing their impact.

Antony Kam 博士于2023年加入西交利物浦大学理学院生物科学系，担任助理教授。他于2010年获得澳大利亚悉尼大学药学院药学学士（荣誉）学位，并于2015年获得该院药学博士学位，主要研究方向为天然产物药理学。毕业后，他加入新加坡南洋理工大学生物科学学院，在世界著名多肽化学家 James P. Tam 教授的指导下工作（2014-2023年），先后担任研究员（Research Fellow）和高级研究员（Senior Research Fellow）。

Kam 博士的研究兴趣主要集中在多肽与蛋白质药物的发现及其转化研究，应用领域涵盖精准医疗、药妆、诊疗一体化以及食品科学。自2010年以来，Kam 博士在《美国化学会志》(Journal of the American Chemical Society)、《德国应用化学》(Angewandte Chemie)、《药物化学杂志》(Journal of Medicinal Chemistry)、《生物化学杂志》(Journal of Biological Chemistry)、《药学学报》英文版 (Acta Pharmaceutica Sinica B)、《药理学前沿》(Frontiers in Pharmacology) 和《植物科学前沿》(Frontiers in Plant Sciences) 等国际知名学术期刊上发表了40多篇经同行评审的学术论文。此外，他还拥有两项处于中美国家阶段的专利申请，涉及用于伤口愈合、化妆品和细胞农业领域的超稳定表皮生长因子受体（EGFR）激动剂的发现。

XPad（西浦多肽与药物，XJTLU Peptide and Drug）是由西交利物浦大学生物科学系的 Antony Kam 博士和慧湖药学院的 Shining Loo 博士共同领导的合作研究团队。该团队处于多肽技术领域的前沿，充分利用在分子药理学、合成生物学和化学生物学方面的专业知识，致力于为以下领域开发创新解决方案：

• 疾病治疗 (Therapeutics)： 设计具有精准靶向性的下一代药物，以对抗各类疾病。
• 医疗诊断 (Diagnostics)： 开发高精度、个性化的医学检测方法，用于疾病的早期筛查和个性化治疗。
• 生物材料 (Biomaterials)： 研发用于组织再生和修复的先进材料，促进伤口愈合，改善人类生活质量。
• 药物递送系统 (Drug Delivery Systems)： 革新治疗药物的安全有效递送方式，以实现药效最大化。

He welcomes interested academic and industrial collaborations, as well as students to join his research projects.Interest parties can contact via e-mail: Antony.kam@xjtlu.edu.cn

Read more about our XPad XJTLU Peptide and Drug research group!

https://connect.xjtlu.edu.cn/group/xpad

Peptide drug discovery and design

High-throughput drug screening

Chemical and genetic-encoded combinatorial library

Solid-phase peptide synthesis

Mass spectrometry-based proteomics analysis

Chemical biology

Molecular pharmacology

Cystine-stabilized microproteins

Natural products

Precision medicine

Food science

Cosmeceuticals

Assistant Professor, School of Biological Sciences, Xian JiaoTong Liverpool University, China - 2023 to present

Adjunct Associate Professor at School of Biosciences, Taylor's University, Malaysia - 2024 to present

Senior Research Fellow in the laboratory of Professor James P. Tam, School of Biological Sciences, Nanyang Technological University, Singapore - 2020 to 2023

Research Fellow in the laboratory of Professor James P. Tam, School of Biological Sciences, Nanyang Technological University, Singapore - 2014 to 2020

BIO205 Cell Biology Techniques

BIO302 Biochemical Messengers

Best Poster award - Frontiers in Peptide Science and Drug Discovery Symposium, Singapore - 2022.

Mistletoe Research Fellow, Momental Foundation, USA - 2021

ASBMB 2018 Graduate/Postdoctoral Travel Award - Experimental Biology 2018, San Diego, USA - 2018

Peptide Therapeutic Foundation Travel Award - 11th Peptide therapeutic Symposium 2016, San Diego, USA - 2016

2013 Postgraduate Research Support Scheme (PRSS) Travel Grant – University of Sydney, Australia - 2013

University of Sydney Postgraduate Award (UPA) Research Scholarship – University of Sydney, Australia

2012 CGCM Travel Grant – 11th Meeting of Consortium for Globalization of Chinese Medicine (CGCM), Macau, China - 2012

2012 Postgraduate Research Support Scheme (PRSS) Travel Grant – University of Sydney, Australia - 2012

2011 CGCM Travel Grant – 10th Meeting of Consortium for Globalization of Chinese Medicine (CGCM), Shanghai, China -2011